Chronic Pain: Why It Lasts Longer in Women – Immune Cell Differences Explained

Women experience chronic pain for longer durations than men, and new research suggests differences in immune cells regulated by hormones, called monocytes, may help explain why. This discovery sheds light on a long-standing disparity in pain perception and offers potential avenues for more effective, targeted treatments.

Unraveling the Biological Basis of Pain Discrepancies

Researchers at Michigan State University, publishing their findings in Science Immunology, have identified a specific subset of monocytes that release a molecule designed to inhibit pain. The study revealed that these pain-inhibiting cells are more active in men, due to higher levels of sex hormones like testosterone. Conversely, women exhibit lower activity in these same monocytes, contributing to more prolonged pain and slower recovery.

Geoffroy Laumet, associate professor of physiology at MSU, and Jaewon Sim, a former graduate student in his lab, discovered this consistent pattern. The team’s investigation, initially a small pilot project, revealed higher levels of interleukin-10 (IL-10) in men – a substance that signals neurons to suppress pain. Further analysis using high-dimensional spectral flow cytometry confirmed that IL-10 producing monocytes were more active in men than in women.

A Shift in Understanding Pain Resolution

This research challenges the traditional view of pain as a purely sensory experience. According to Laumet, pain resolution isn’t a passive process, but an active one driven by the immune system. By blocking male sex hormones, researchers were able to reverse the effect, demonstrating a clear link between hormonal influence and immune cell activity in pain management.

Researchers, including Sarah Linnsteadt from the University of North Carolina at Chapel Hill, who studies the psychological consequences of accidents, corroborated these findings. Her work showed a similar pattern: men exhibited more active IL-10 producing monocytes and experienced faster pain relief.

Looking Ahead: Potential for New Therapies

While a new treatment is likely decades away, this research offers hope for developing therapies that stimulate IL-10 production, accelerating pain resolution without relying on opioids. Laumet emphasizes the importance of validating the biological basis of pain differences between men and women, ensuring that women’s pain is taken seriously.

Frequently Asked Questions

What role do monocytes play in pain management?

Monocytes, a type of immune cell, produce a molecule called interleukin-10 (IL-10) that signals neurons to suppress pain. Researchers found that these cells are more active in men, contributing to faster pain relief.

Why does pain last longer in women, according to this study?

Women experience more prolonged pain due to lower activity in the specific subset of monocytes responsible for releasing pain-inhibiting molecules. This lower activity is linked to hormonal differences.

Is this research likely to lead to new treatments for chronic pain?

This research could pave the way for therapies that stimulate the production of IL-10, potentially offering a non-opioid approach to accelerate pain resolution. However, a new treatment is likely decades away.

How might a deeper understanding of the biological basis of pain influence the way healthcare providers approach chronic pain management?